TYPE III PROCOLLAGEN PEPTIDE: A MARKER OF DISEASE ACTIVITY AND PROGNOSIS IN PRIMARY BILIARY CIRRHOSIS
- 1 May 1988
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 331 (8593), 1021-1024
- https://doi.org/10.1016/s0140-6736(88)91843-0
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Liver transplantationCurrent Opinion in Gastroenterology, 1987
- Serum aminoterminal procollagen type III peptide in acute viral hepatitis. A long‐term follow‐up studyLiver International, 1987
- Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosisGastroenterology, 1985
- Treatment of Primary Biliary CirrhosisSeminars in Liver Disease, 1985
- A radioimmunoassay procedure for type III procollagen: Its use in the detection of hepatic fibrosisHepatology, 1985
- Long-Term Follow-Up of Serum N-Terminal Propeptide of Collagen Type III Levels in Patients with Chronic Liver DiseaseHepatology, 1984
- The N-Terminal Propeptide of Collagen Type III in Serum Reflects Activity and Degree of Fibrosis in Patients with Chronic Liver DiseaseHepatology, 1984
- The Prognostic Importance of Clinical and Histologic Features in Asymptomatic and Symptomatic Primary Biliary CirrhosisNew England Journal of Medicine, 1983
- Radioimmunoassay for type III procollagen peptide and its application to human liver diseaseEuropean Journal of Clinical Investigation, 1979
- Serum bilirubin: a prognostic factor in primary biliary cirrhosis.Gut, 1979